TY - JOUR T1 - Research advances and clinical management of bronchiectasis: Chinese perspective JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00017-2022 VL - 8 IS - 2 SP - 00017-2022 AU - Jin-fu Xu AU - Yong-hua Gao AU - Yuan-lin Song AU - Jie-ming Qu AU - Wei-jie Guan Y1 - 2022/04/01 UR - http://openres.ersjournals.com/content/8/2/00017-2022.abstract N2 - Bronchiectasis is a debilitating chronic suppurative airway disease that confers a substantial burden globally. Despite the notable prevalence, research on bronchiectasis in mainland China remains in its infancy. Nevertheless, there has been a significant leap in the quantity and quality of research, which has contributed to the ever-improving clinical practice. A nationwide collaborative platform has been established to foster multicentre studies, which will help increase the level of evidence further. Here, we summarise the status quo of clinical management and consider the research priorities for bronchiectasis that have been published previously. We also highlight the efforts of the Chinese medical communities to outline the core tasks that need to be addressed within the next decade.The remarkable progress made in bronchiectasis research has revolutionised clinical practice in mainland China https://bit.ly/3K8kQYr ER -